An Evaluation of the Safety and Tolerability of Ocular Lubricants
NCT ID: NCT07238699
Last Updated: 2025-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
148 participants
INTERVENTIONAL
2026-03-31
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Comfort in Subjects With Moderate Dry Eye Disease
NCT04830956
Evaluation of Safety and Tolerability of Ocular Lubricants
NCT05573360
Evaluate Artificial Tear Efficacy in Moderate to Severe Dry Eye
NCT00724412
Evaluation of Comfort of Ocular Lubricants in Symptomatic Contact Lens Wearers
NCT05741216
An Evaluation of a Marketed Lubricated Eye Drop in Soft Contact Lens Wearers Who Experience Ocular Dryness
NCT01132287
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sequence 1: FID123440, then FID123437
One drop of FID123440 test formulation in each eye in Period 1, followed by 1 drop of FID123437 test formulation in each eye in Period 2 as randomized. Each period is 1 day long with at least 2 calendar days separating the periods.
FID123440 test formulation
Investigational product
FID123437 test formulation
Investigational product
Sequence 2: FID123437, then FID123440
One drop of FID123437 test formulation in each eye in Period 1, followed by 1 drop of FID123440 test formulation in each eye in Period 2 as randomized. Each period is 1 day long with at least 2 calendar days separating the periods.
FID123437 test formulation
Investigational product
FID123440 test formulation
Investigational product
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FID123440 test formulation
Investigational product
FID123437 test formulation
Investigational product
FID123440 test formulation
Investigational product
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject must be willing and able to attend all study visits as required by the protocol.
* Subject must exhibit symptoms of dry eye at the Screening Visit.
* Subject must currently use artificial tears.
Exclusion Criteria
* Has any known infection or inflammation that requires treatment or has a systemic condition that, in the opinion of the investigator, may affect a study outcome variable.
* Any ocular injury to either eye in the 12 weeks prior to screening.
* Current wearer of contact lenses or has a history of contact lens wear within the previous 1 month.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trial Lead, Dry Eye
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Contact Alcon Call Center for Trial Locations
Fort Worth, Texas, United States
School of Optometry and Vision
Sydney, New South Wales, Australia
Ophthalmic Trials Australia
Teneriffe, Queensland, Australia
The University of Melbourne, Department of Optometry and Vision Science
Carlton, Victoria, Australia
Deakin Collaborative Eye Care Clinic, Deakin University
Waurn Ponds, Victoria, Australia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DEE253-E003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.